Translation and Validation of the Spanish Version of the Banff Patellofemoral Instability Instrument 2.0
被引:0
|
作者:
Martinez-Cano, Juan Pablo
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Valle Lili, Dept Ortopedia, Cali, Colombia
Univ ICESI, Cali, ColombiaFdn Valle Lili, Dept Ortopedia, Cali, Colombia
Martinez-Cano, Juan Pablo
[1
,2
]
Iversen, Maura D.
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Valle Lili, Dept Ortopedia, Cali, Colombia
Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, Sweden
Johnson & Wales Univ, Coll Hlth & Wellness, Providence, RI USA
Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Immun, Sect Clin Sci, Boston, MA USA
Harvard Med Sch, Dept Med, Boston, MA USAFdn Valle Lili, Dept Ortopedia, Cali, Colombia
Iversen, Maura D.
[1
,3
,4
,5
,6
]
Gallego, Alejandro
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Valle Lili, Dept Ortopedia, Cali, ColombiaFdn Valle Lili, Dept Ortopedia, Cali, Colombia
Gallego, Alejandro
[1
]
Gallon, Luis Alfonso
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Valle Lili, Dept Ortopedia, Cali, Colombia
Univ ICESI, Cali, ColombiaFdn Valle Lili, Dept Ortopedia, Cali, Colombia
Gallon, Luis Alfonso
[1
,2
]
Askenberger, Marie
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Valle Lili, Dept Ortopedia, Cali, Colombia
Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, SwedenFdn Valle Lili, Dept Ortopedia, Cali, Colombia
Askenberger, Marie
[1
,3
]
von Heideken, Johan
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Valle Lili, Dept Ortopedia, Cali, Colombia
Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, SwedenFdn Valle Lili, Dept Ortopedia, Cali, Colombia
von Heideken, Johan
[1
,3
]
机构:
[1] Fdn Valle Lili, Dept Ortopedia, Cali, Colombia
[2] Univ ICESI, Cali, Colombia
[3] Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, Sweden
[4] Johnson & Wales Univ, Coll Hlth & Wellness, Providence, RI USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Immun, Sect Clin Sci, Boston, MA USA
Background: The Banff Patellofemoral Instability Instrument (BPII) 2.0 is a patient-reported outcome measure (PROM) tailored specifically for patellofemoral instability. The BPII 2.0 was developed in English and has been validated for adolescents and translated into several languages, but not into Spanish.Purpose/Hypothesis: This investigation involved translating the BPII 2.0 into Spanish and evaluating and validating its psychometric properties. It was hypothesized that there would be a moderate correlation between the Spanish BPII 2.0 and the Spanish version of the Kujala score.Study Design: Cohort study (diagnosis); Level of evidence, 3.Methods: The BPII 2.0 underwent forward and backward translations into Colombian Spanish according to the Consensus-Based Standards for the Selection of Health Measurement Instrument guidelines. Colombian patients aged 9 to 18 years who experienced knee symptoms after a primary or recurrent patellar dislocation were recruited from a hospital-based orthopaedic clinic. Participants completed the Spanish BPII 2.0 and the Kujala score during their initial visit (t0) and the Spanish BPII 2.0 again 1 week later (t1). Internal consistency and test-retest reliability were assessed using the intraclass correlation coefficient (ICC). Concurrent validity of the Spanish BPII 2.0 with the Kujala score was explored through Pearson correlation analysis.Results: A total of 46 participants (31 [67%] female; mean age, 15.1 +/- 2.0 years) were included. The mean time since first patellofemoral dislocation was 22 +/- 28 months. Of the 4 participants who received operative treatment for patellar instability, the mean time since surgery was 12 months (range, 7-18 months). All patients completed the BPII 2.0 at t0 and at t1, a mean of 7 days later (range, 6-7 days), and 45 (98%) participants completed the Kujala score at t0. Five Spanish BPII 2.0 items exhibited floor or ceiling effects, however no subscales demonstrated these effects. Th Spanish BPII 2.0 demonstrated excellent internal consistency at both t0 (ICC, 0.94; 95% CI, 0.92-0.96) and t1 (ICC, 0.96; 95% CI, 0.93-0.97), along with excellent test-retest reliability (ICC, 0.98; 95% CI, 0.97-0.99). Concurrent validity of the Spanish BPII 2.0 with the Spanish Kujala score was good to strong (r = 0.74; 95% CI, 0.57-0.85).Conclusion: The Spanish BPII 2.0 had excellent internal consistency and test-retest reliability, suggesting this PROM is a reliable and valid questionnaire.
机构:
Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Duke Univ, Med Ctr, Dept Med, Duke Comprehens Canc Ctr, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Abernethy, Amy P.
Zafar, Syed Yousuf
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Duke Univ, Med Ctr, Dept Med, Duke Comprehens Canc Ctr, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Zafar, Syed Yousuf
Uronis, Hope
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Uronis, Hope
Wheeler, Jane L.
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Wheeler, Jane L.
Coan, April
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Dept Med, Duke Comprehens Canc Ctr, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Coan, April
Rowe, Krista
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Rowe, Krista
Shelby, Rebecca A.
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Shelby, Rebecca A.
Fowler, Robin
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA
Fowler, Robin
Herndon, James E., II
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Med Ctr, Dept Med, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USADuke Univ, Med Ctr, Div Med Oncol, Durham, NC 27710 USA